Aldosterone promotes cardiac endothelial cell proliferation in vivo

Basile Gravez1, Antoine Tarjus1, Véronique Pelloux2

  • 1Inserm U1138, Team 1, 15 rue de l'école de médecine, Paris, France (B.G., A.T., N.F., F.J., S.M.).

Abstract

Insights

Aldosterone alone, not just with salt, drives heart cell division, primarily in endothelial cells. This mineralocorticoid receptor-dependent process is a novel finding in cardiac biology.

Area of Science:

  • Cardiovascular Biology
  • Endocrinology
  • Molecular Cardiology

Background:

  • Aldosterone in conjunction with NaCl causes cardiac fibrosis, oxidative stress, and inflammation via mineralocorticoid receptor activation.
  • The specific biological processes regulated by aldosterone alone in the heart were previously unidentified.

Purpose of the Study:

  • To elucidate the cardiac biological processes regulated by aldosterone independently.
  • To investigate the role of aldosterone in cardiac cell proliferation.

Main Methods:

  • Cardiac transcriptome analysis in mice treated with aldosterone.
  • Gene ontology analysis to identify biological processes.
  • Immunohistochemical staining for Ki-67 to assess cell proliferation.
  • Ex vivo studies using human endothelial cells.
  • Preclinical heart failure model (transverse aortic constriction) with eplerenone treatment.

Main Results:

  • Aldosterone modulated 60 cardiac transcripts (51 upregulated, 9 downregulated) in mice.
  • Gene ontology analysis revealed aldosterone-regulated genes are predominantly involved in cell division.
  • Aldosterone treatment significantly increased the cardiac Ki-67 proliferation index.
  • Proliferating cells were identified as endothelial cells.
  • Aldosterone-induced mineralocorticoid receptor-dependent endothelial cell proliferation was confirmed ex vivo and inhibited by eplerenone in vivo.

Conclusions:

  • Aldosterone independently modulates cardiac gene expression.
  • Aldosterone induces cardiac endothelial cell proliferation in vivo.
  • Mineralocorticoid receptor blockade inhibits aldosterone-induced endothelial cell proliferation.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.1K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.9K
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
37.5K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.3K
Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
69.8K